US Stocks
/
Altimmune, Inc. Share Price

Altimmune, Inc. Share Price

NASDAQ: ALT | Micro Cap
$3.07
+$0.06 (1.99%) Last updated on 08 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Altimmune, Inc. Stock Performance

Open
$3.04
Prev. Close
$3.01
Circuit Range
N/A
Day Range
$3.00 - $3.10
Year Range
$2.56 - $6.42
Volume
2,88,968
Average Traded
$3.06

Altimmune, Inc. Share Price Today

As of 10 August 2026, Altimmune, Inc.'s share price is $3.07. The stock opened at $3.04, compared to its previous close of $3.01. During today's trading session, Altimmune, Inc.'s share price traded between $3.00 and $3.10, with an average price of $3.05. Over the past 52 weeks, the stock has recorded a high of $6.42 and a low of $2.56. In terms of performance, Altimmune, Inc.'s share price has declined by 28.77% over the last six months and is down 19.63% on a year-on-year basis.

Altimmune, Inc. Share Price Chart

$3.00$3.10
L
Show Current Price
H

Altimmune, Inc. Stock Fundamentals & Key Indicators

Market Cap
$270.48M
PE Ratio (TTM)
-3.07
Dividend Yield
N/A
EPS (TTM)
$-1.00
Revenue (TTM)
$41000.00
Return On Equity (TTM)
-39.17%
Profit Margin
-214860.98%
Debt to Equity
0.07
Quarterly Earnings Growth YoY
16.77%

Altimmune, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
Revenue$5000.00$5000.00$5000.00$5000.00$5000.00$5000.00
Net Profit-$24.39M-$24.64M-$22.84M-$19.57M-$22.15M-$19.01M
Net Profit Margin-487880.00%-492800.00%-456900.00%-391500.00%-442920.00%-380280.00%
Income ChangeN/A-1.01%7.28%14.31%-13.13%14.14%

Altimmune, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
Revenue$4.41M-$68000.00$426000.00$20000.00$41000.00
Net Profit-$97.09M-$84.71M-$88.45M-$95.06M-$88.09M
Net Profit Margin-2201.43%124577.94%-20762.21%-475295.00%-214860.98%
Income ChangeN/A12.75%-4.41%-7.48%7.33%

About Altimmune, Inc.

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

Altimmune, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$2.90
$3.07
+7.72%
Jul 2026
$3.06
$2.85
-5.79%
Jun 2026
$3.03
$3.02
-0.82%
May 2026
$2.57
$3.05
+18.22%
Apr 2026
$3.15
$2.58
-15.96%
Mar 2026
$4.22
$3.07
-28.77%
Feb 2026
$5.55
$4.31
-23.17%
Jan 2026
$3.62
$5.61
+55.62%
Dec 2025
$5.08
$3.60
-31.46%
Nov 2025
$4.02
$5.26
+29.88%
Oct 2025
$3.83
$4.05
+7.43%
Sep 2025
$3.79
$3.77
-1.31%

ALT Share Price FAQs

What is Altimmune, Inc. share price today?

chevron-up
Altimmune, Inc. share price today is $3.07 as on August 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Altimmune, Inc. stock?

chevron-up
The 52 week high of Altimmune, Inc. stock is $6.42, while the 52 week low is $2.56 as of 8 Aug '26.

What is ALT's market capitalisation today?

chevron-up
ALT market capitalisation is $270.48M as of August 10, 2026, at 5:37 am IST.

What is ALT's net income for the last quarter?

chevron-up
ALT's net income for the last quarter is -0.02B USD.

What is the 5 year returns of ALT?

chevron-up
The 5 year returns of ALT is -79.51% as on 8 Aug '26.

What is the high & low stock price of ALT today?

chevron-up
ALT stock price hit a high of $3.10 and low of $3.00 as of 8 Aug '26.

Can I buy ALT shares in India?

chevron-up
Yes. You can buy ALT in India by opening an international trading account.